🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/04/2001 | 5,59 | 5,65 | 5,38 | 5,42 | -2,78% | 4,92% | 277.200 |
| 23/04/2001 | 5,63 | 5,66 | 5,47 | 5,57 | -2,71% | 3,29% | 146.800 |
| 20/04/2001 | 5,79 | 5,84 | 5,57 | 5,73 | -2,55% | 4,58% | 384.200 |
| 19/04/2001 | 5,61 | 5,93 | 5,50 | 5,88 | +4,44% | 7,58% | 902.000 |
| 18/04/2001 | 5,63 | 5,75 | 5,44 | 5,63 | +1,99% | 5,60% | 1.227.000 |
| 17/04/2001 | 5,62 | 5,62 | 5,43 | 5,52 | -2,48% | 3,29% | 1.383.200 |
| 16/04/2001 | 5,35 | 6,18 | 5,03 | 5,66 | -24,09% | 21,50% | 3.586.000 |
| 12/04/2001 | 7,45 | 7,45 | 7,25 | 7,45 | +3,83% | 2,68% | 316.400 |
| 11/04/2001 | 7,50 | 7,56 | 7,13 | 7,18 | -2,84% | 5,80% | 396.200 |
| 10/04/2001 | 7,73 | 7,74 | 7,38 | 7,39 | -3,90% | 4,66% | 233.200 |
| 09/04/2001 | 7,52 | 7,69 | 7,45 | 7,69 | +1,62% | 3,19% | 258.400 |
| 06/04/2001 | 7,88 | 8,00 | 7,53 | 7,56 | -5,10% | 5,95% | 204.000 |
| 05/04/2001 | 7,38 | 7,97 | 7,19 | 7,97 | +7,59% | 10,59% | 353.200 |
| 04/04/2001 | 7,13 | 7,50 | 6,97 | 7,41 | +4,41% | 7,46% | 254.800 |
| 03/04/2001 | 7,75 | 7,81 | 7,00 | 7,09 | -9,92% | 10,48% | 178.800 |
| 02/04/2001 | 8,69 | 8,75 | 7,56 | 7,88 | -9,68% | 13,67% | 493.800 |
| 30/03/2001 | 8,00 | 8,75 | 7,94 | 8,72 | +8,99% | 10,16% | 493.600 |
| 29/03/2001 | 7,78 | 8,88 | 7,78 | 8,00 | +2,40% | 14,06% | 774.200 |
| 28/03/2001 | 7,81 | 8,13 | 7,69 | 7,81 | -3,85% | 5,60% | 283.600 |
| 27/03/2001 | 8,18 | 8,25 | 7,94 | 8,13 | +2,77% | 3,82% | 549.400 |
| 26/03/2001 | 8,00 | 8,41 | 7,88 | 7,91 | +1,20% | 6,64% | 758.600 |
| 23/03/2001 | 8,03 | 8,88 | 7,56 | 7,81 | -0,79% | 16,34% | 804.000 |
| 22/03/2001 | 7,82 | 8,19 | 6,88 | 7,88 | -2,70% | 16,78% | 765.400 |
| 21/03/2001 | 7,81 | 8,25 | 7,56 | 8,09 | -2,63% | 8,80% | 504.200 |
| 20/03/2001 | 9,06 | 9,06 | 8,25 | 8,31 | -7,64% | 8,97% | 487.600 |
| 19/03/2001 | 8,25 | 9,00 | 8,13 | 9,00 | +6,27% | 10,61% | 586.400 |
| 16/03/2001 | 8,23 | 8,59 | 8,22 | 8,47 | +3,44% | 4,55% | 833.200 |
| 15/03/2001 | 7,88 | 8,47 | 7,88 | 8,19 | +3,97% | 7,54% | 304.800 |
| 14/03/2001 | 7,63 | 8,66 | 7,13 | 7,88 | +2,86% | 20,08% | 552.800 |
| 13/03/2001 | 7,16 | 7,75 | 6,88 | 7,66 | +8,89% | 12,23% | 760.400 |